Genome-wide Association Studies-GWAS
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Quality Control
Genetic Screens
Strategies for Assessing and Addressing Confounding
Comparing Copy Number Variations and SNPs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 6, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Carl A Anderson1, Fredrik H Pettersson, Geraldine M Clarke
1Genetic and Genomic Epidemiology Unit, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK. carl.anderson@sanger.ac.uk
This protocol outlines essential data quality control steps for case-control association studies. It details using PLINK and SMARTPCA to remove biased DNA samples and markers, ensuring reliable genetic association findings.
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
08:27Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: